Pacira Pharmaceuticals Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
48.70USD
25 Sep 2018
48.70USD
25 Sep 2018
Change (% chg)
$-1.75 (-3.47%)
$-1.75 (-3.47%)
Prev Close
$50.45
$50.45
Open
$50.40
$50.40
Day's High
$50.45
$50.45
Day's Low
$48.58
$48.58
Volume
393,274
393,274
Avg. Vol
150,826
150,826
52-wk High
$52.55
$52.55
52-wk Low
$26.98
$26.98
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 0.09 | December | 26 Sep 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 3 | 3 |
| (2) OUTPERFORM | 5 | 7 | 6 | 6 |
| (3) HOLD | 8 | 8 | 9 | 9 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 2 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.71 | 2.50 | 2.47 | 2.47 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 16 | 80.66 | 85.00 | 78.14 | 90.57 |
| Quarter Ending Dec-18 | 16 | 89.12 | 92.70 | 84.00 | 102.75 |
| Year Ending Dec-18 | 16 | 327.02 | 330.73 | 322.92 | 364.39 |
| Year Ending Dec-19 | 17 | 376.49 | 414.81 | 327.00 | 447.83 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 15 | 0.09 | 0.18 | 0.01 | 0.26 |
| Quarter Ending Dec-18 | 15 | 0.19 | 0.34 | 0.01 | 0.39 |
| Year Ending Dec-18 | 14 | 0.54 | 0.67 | 0.35 | 1.02 |
| Year Ending Dec-19 | 15 | 1.24 | 1.87 | -0.44 | 2.30 |
| LT Growth Rate (%) | 1 | 78.00 | 78.00 | 78.00 | 43.10 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-18 | 79.13 | 81.11 | 1.98 | 2.50 |
| Quarter Ending Mar-18 | 73.83 | 74.61 | 0.77 | 1.05 |
| Quarter Ending Dec-17 | 79.32 | 79.08 | 0.24 | 0.31 |
| Quarter Ending Sep-17 | 69.65 | 67.33 | 2.31 | 3.32 |
| Quarter Ending Jun-17 | 73.43 | 70.93 | 2.49 | 3.40 |
| Earnings (per share) | ||||
| Quarter Ending Jun-18 | 0.07 | 0.24 | 0.17 | 226.53 |
| Quarter Ending Mar-18 | 0.02 | 0.02 | 0.00 | 16.32 |
| Quarter Ending Dec-17 | 0.10 | 0.38 | 0.28 | 297.49 |
| Quarter Ending Sep-17 | -0.06 | 0.11 | 0.17 | -298.92 |
| Quarter Ending Jun-17 | -0.05 | -0.11 | 0.06 | -127.74 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 80.66 | 80.79 | 80.34 | 76.62 | 90.57 |
| Quarter Ending Dec-18 | 89.12 | 88.99 | 89.17 | 86.13 | 102.75 |
| Year Ending Dec-18 | 327.02 | 327.08 | 327.20 | 315.73 | 364.39 |
| Year Ending Dec-19 | 376.49 | 375.91 | 376.42 | 363.43 | 447.83 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 0.09 | 0.09 | 0.09 | 0.04 | 0.26 |
| Quarter Ending Dec-18 | 0.19 | 0.18 | 0.20 | 0.15 | 0.39 |
| Year Ending Dec-18 | 0.54 | 0.54 | 0.56 | 0.29 | 1.02 |
| Year Ending Dec-19 | 1.24 | 1.20 | 1.23 | 0.99 | 2.30 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-18 | 0 | 1 | 0 | 1 |
| Quarter Ending Dec-18 | 1 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 1 | 0 | 1 | 1 |
| Earnings | ||||
| Quarter Ending Sep-18 | 0 | 1 | 0 | 1 |
| Quarter Ending Dec-18 | 1 | 0 | 1 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 1 | 0 | 1 | 1 |
Earnings vs. 
Estimates